Milestone Scientific, Inc. (MLSS): Price and Financial Metrics


Milestone Scientific, Inc. (MLSS): $2.32

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MLSS POWR Grades


  • Sentiment is the dimension where MLSS ranks best; there it ranks ahead of 89.56% of US stocks.
  • The strongest trend for MLSS is in Value, which has been heading up over the past 47 weeks.
  • MLSS ranks lowest in Value; there it ranks in the 18th percentile.

MLSS Stock Summary

  • For MLSS, its debt to operating expenses ratio is greater than that reported by only 9.78% of US equities we're observing.
  • Revenue growth over the past 12 months for Milestone Scientific Inc comes in at 75%, a number that bests 90.63% of the US stocks we're tracking.
  • The volatility of Milestone Scientific Inc's share price is greater than that of 92.66% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Milestone Scientific Inc are LSF, PRPO, ECOR, SIBN, and NWPX.
  • MLSS's SEC filings can be seen here. And to visit Milestone Scientific Inc's official web site, go to www.milestonescientific.com.

MLSS Valuation Summary

  • MLSS's price/sales ratio is 14.2; this is 273.68% higher than that of the median Healthcare stock.
  • MLSS's EV/EBIT ratio has moved down 15.8 over the prior 243 months.
  • Over the past 243 months, MLSS's EV/EBIT ratio has gone down 15.8.

Below are key valuation metrics over time for MLSS.

Stock Date P/S P/B P/E EV/EBIT
MLSS 2021-08-31 14.2 7.1 -20.1 -17.6
MLSS 2021-08-30 14.0 7.0 -19.9 -17.4
MLSS 2021-08-27 14.1 7.0 -20.0 -17.5
MLSS 2021-08-26 12.2 6.1 -17.3 -14.8
MLSS 2021-08-25 12.1 6.0 -17.2 -14.7
MLSS 2021-08-24 12.1 6.0 -17.2 -14.7

MLSS Growth Metrics

  • The 2 year price growth rate now stands at 142.03%.
  • Its year over year net income to common stockholders growth rate is now at 19.56%.
  • Its 2 year cash and equivalents growth rate is now at -63.42%.
Over the past 33 months, MLSS's revenue has gone up $48,668.

The table below shows MLSS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 9.670744 -6.376852 -6.776149
2021-06-30 8.808621 -6.556074 -6.223931
2021-03-31 6.550557 -6.980663 -6.709927
2020-12-31 5.437236 -6.984928 -7.337273
2020-09-30 5.526091 -6.849762 -9.121024
2020-06-30 6.179802 -5.268513 -10.46701

MLSS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MLSS has a Quality Grade of C, ranking ahead of 36.73% of graded US stocks.
  • MLSS's asset turnover comes in at 0.423 -- ranking 112th of 186 Medical Equipment stocks.
  • TNDM, TFX, and PEN are the stocks whose asset turnover ratios are most correlated with MLSS.

The table below shows MLSS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.423 0.616 -2.177
2021-03-31 0.315 0.637 -2.538
2020-12-31 0.325 0.666 -3.651
2020-09-30 0.411 0.683 -7.765
2020-06-30 0.616 0.698 30.088
2020-03-31 1.274 0.690 6.927

MLSS Stock Price Chart Interactive Chart >

Price chart for MLSS

MLSS Price/Volume Stats

Current price $2.32 52-week high $4.85
Prev. close $2.32 52-week low $1.47
Day low $2.09 Volume 211,300
Day high $2.37 Avg. volume 479,377
50-day MA $2.20 Dividend yield N/A
200-day MA $2.44 Market Cap 157.40M

Milestone Scientific, Inc. (MLSS) Company Bio


Milestone Scientific Inc. operates as a medical technology company. The Company manufactures, markets, and sells computer-controlled local anesthetic delivery systems for plastic surgery, podiatry, dermatology, and orthopedics. Milestone Scientific serves medical sector worldwide.


MLSS Latest News Stream


Event/Time News Detail
Loading, please wait...

MLSS Latest Social Stream


Loading social stream, please wait...

View Full MLSS Social Stream

Latest MLSS News From Around the Web

Below are the latest news stories about Milestone Scientific Inc that investors may wish to consider to help them evaluate MLSS as an investment opportunity.

Milestone Scientific Reports 69% Increase in Revenue for Third Quarter of 2021

ROSELAND, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter ended September 30, 2021. Arjan Haverhals, President and Chief Executive Officer of Milestone Scientific, commented, “We are pleased to report continued revenue growth, achieving a 69% increase in revenue to $2.1 mil

Yahoo | November 15, 2021

Milestone Scientific Schedules Third Quarter 2021 Business Update Conference Call

ROSELAND, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, November 15, 2021 to discuss the Company’s financial results for the third quarter ended September 30, 2021, as well as the Company’s corporate progress and other developments. The conference call will be available vi

Yahoo | November 11, 2021

Star Bulk Carriers (SBLK) Reports Next Week: Wall Street Expects Earnings Growth

Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Entrepreneur.com | November 9, 2021

Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | November 9, 2021

Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021

ROSELAND, N.J., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific, will present at the Dawson James Securities Small Cap Growth Conference being held on October 21, 2021 at the Wyndham Grand Hotel in Jupiter, Florida.

Intrado Digital Media | October 18, 2021

Read More 'MLSS' Stories Here

MLSS Price Returns

1-mo 14.85%
3-mo 25.41%
6-mo 14.85%
1-year 40.61%
3-year 337.74%
5-year 36.47%
YTD 9.43%
2020 52.52%
2019 318.67%
2018 -71.86%
2017 -15.71%
2016 -40.43%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7121 seconds.